Defence Therapeutics Inc. (DTC) — Financial Flexibility Index
Defence Therapeutics Inc. (DTC) has a Financial Flexibility Index of -0.54x as of December 2025. Free cash flow of €-1.40 Million (operating CF €-1.40 Million minus capex €0.00) represents -1% of total liabilities (€2.59 Million). Check Defence Therapeutics Inc. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Defence Therapeutics Inc. Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for Defence Therapeutics Inc. across 5 annual periods. For the full cash flow conversion analysis, see DTC cash flow conversion.
Annual Financial Flexibility Index for Defence Therapeutics Inc. (2020–2024)
Year-by-year free cash flow to debt coverage for Defence Therapeutics Inc.. Explore debt repayment capacity of Defence Therapeutics Inc. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.01x | €-4.09 Million | €-4.29 Million | €4.06 Million | ▲ +73.9% |
| 2023 | -3.86x | €-7.59 Million | €-7.66 Million | €1.97 Million | ▲ +29.3% |
| 2022 | -5.46x | €-6.04 Million | €-6.04 Million | €1.11 Million | ▲ +70.9% |
| 2021 | -18.73x | €-2.29 Million | €-2.29 Million | €122.26K | ▼ -943.1% |
| 2020 | -1.80x | €-86.81K | €-132.83K | €48.35K | — |